dc.contributor.author | Streinu-Cercel, A. | |
dc.contributor.author | Tabak, F. | |
dc.contributor.author | Akarca, U. S. | |
dc.contributor.author | Hansen, B. | |
dc.contributor.author | Janssen, H. L. | |
dc.contributor.author | Brouwer, W. P. | |
dc.contributor.author | Sonneveld, M. J. | |
dc.contributor.author | Xie, Q. | |
dc.contributor.author | Zhang, N. | |
dc.contributor.author | Zeuzem, S. | |
dc.contributor.author | Zhang, Q. | |
dc.contributor.author | Simon, K. | |
dc.date.accessioned | 2021-03-02T21:39:22Z | |
dc.date.available | 2021-03-02T21:39:22Z | |
dc.identifier.citation | Brouwer W. P. , Sonneveld M. J. , Xie Q., Zhang N., Zeuzem S., Tabak F., Zhang Q., Simon K., Akarca U. S. , Streinu-Cercel A., et al., "CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA", 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 22 - 26 Nisan 2015, cilt.62 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0838934f-95e0-4bda-90a3-385ba8bcfddf | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/11336 | |
dc.identifier.uri | https://doi.org/10.1016/s0168-8278(15)30873-4 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA | |
dc.type | Bildiri | |
dc.contributor.department | Erasmus University Rotterdam , , | |
dc.identifier.volume | 62 | |
dc.contributor.firstauthorID | 146397 | |